Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-12-04

FDA Approved: FINGOLIMOD — Original Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approves Sun Pharmaceutical's original application for fingolimod (generic) for relapsing forms of multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fingolimod (fingolimod)

Snippet

ORIG AP for FINGOLIMOD (FINGOLIMOD)